EFFECT OF FLUVASTATIN SODIUM (XU62-320), A NEW INHIBITOR OF 3-HYDROXY-3-METHYLGLUTARYL COENZYME-A REDUCTASE, ON THE INDUCTION OF LOW-DENSITY-LIPOPROTEIN RECEPTOR IN HEPG2 CELLS

被引：34

作者：

HAYASHI, K

KUROKAWA, J

NOMURA, S

KUGA, Y

OHKURA, Y

KAJIYAMA, G

机构：

[1] First Department of Internal Medicine, Hiroshima University School of Medicine, Minami-ku, Hiroshima

来源：

BIOCHIMICA ET BIOPHYSICA ACTA | 1993年 / 1167卷 / 02期

关键词：

FLUVASTATIN SODIUM (XU62-320); HMG-COA REDUCTASE INHIBITOR; LDL RECEPTOR; HEPG2; CELL;

D O I：

10.1016/0005-2760(93)90166-7

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

The effect of fluvastatin sodium (XU62-320), a new type of inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A, on the induction of LDL receptor in the human liver-derived cell line HepG2 was investigated. Fluvastatin sodium produced marked inhibition of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity and induction of LDL receptor on HepG2 cells at a concentration of 0.1-1.0 muM. These results suggest that fluvastatin sodium has potential for use as a strong plasma cholesterol-lowering drug.

引用

页码：223 / 225

页数：3

共 10 条

[1]

[Anonymous], 1984, LANCET, V2, P600

[2] REGRESSION OF CORONARY-ARTERY DISEASE AS A RESULT OF INTENSIVE LIPID-LOWERING THERAPY IN MEN WITH HIGH-LEVELS OF APOLIPOPROTEIN-B [J].

BROWN, G ;

ALBERS, JJ ;

FISHER, LD ;

SCHAEFER, SM ;

LIN, JT ;

KAPLAN, C ;

ZHAO, XQ ;

BISSON, BD ;

FITZPATRICK, VF ;

DODGE, HT .

NEW ENGLAND JOURNAL OF MEDICINE, 1990, 323 (19) :1289-1298

[3] HELSINKI HEART-STUDY - PRIMARY-PREVENTION TRIAL WITH GEMFIBROZIL IN MIDDLE-AGED MEN WITH DYSLIPIDEMIA - SAFETY OF TREATMENT, CHANGES IN RISK-FACTORS, AND INCIDENCE OF CORONARY HEART-DISEASE [J].

FRICK, MH ;

ELO, O ;

HAAPA, K ;

HEINONEN, OP ;

HEINSALMI, P ;

HELO, P ;

HUTTUNEN, JK ;

KAITANIEMI, P ;

KOSKINEN, P ;

MANNINEN, V ;

MAENPAA, H ;

MALKONEN, M ;

MANTTARI, M ;

NOROLA, S ;

PASTERNACK, A ;

PIKKARAINEN, J ;

ROMO, M ;

SJOBLOM, T ;

NIKKILA, EA .

NEW ENGLAND JOURNAL OF MEDICINE, 1987, 317 (20) :1237-1245

[4]

HAYASHI K, 1989, J BIOL CHEM, V264, P3131

[5]

HAYASHI K, 1991, BIOCHIM BIOPHYS ACTA, V1082, P152

[6]

HJERMANN I, 1981, LANCET, V2, P1303

[7] INDUCTION OF MESSENGER-RNA FOR LOW-DENSITY LIPOPROTEIN RECEPTORS IN HETEROZYGOUS WATANABE HERITABLE HYPERLIPIDEMIC RABBITS TREATED WITH CS-514 (PRAVASTATIN) AND CHOLESTYRAMINE [J].

KUME, N ;

KITA, T ;

MIKAMI, A ;

YOKODE, M ;

ISHII, K ;

NAGANO, Y ;

KAWAI, C .

CIRCULATION, 1989, 79 (05) :1084-1090

[8]

OHTANI H, 1990, J LIPID RES, V31, P1413

[9] IS RELATIONSHIP BETWEEN SERUM-CHOLESTEROL AND RISK OF PREMATURE DEATH FROM CORONARY HEART-DISEASE CONTINUOUS AND GRADED - FINDINGS IN 356 222 PRIMARY SCREENEES OF THE MULTIPLE RISK FACTOR INTERVENTION TRIAL (MRFIT) [J].

STAMLER, J ;

WENTWORTH, D ;

NEATON, JD .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1986, 256 (20) :2823-2828

[10]

1984, JAMA-J AM MED ASSOC, V251, P351

← 1 →